ARTICLE | Clinical News
Zinapar darinaparsin regulatory update
January 31, 2011 8:00 AM UTC
The COMP issued a positive opinion to grant Orphan Drug designation for Ziopharm's Zinapar darinaparsin to treat peripheral T cell lymphoma (PTCL). Ziopharm expects to begin a Phase I trial of the IV ...